Inventor · disambiguated record
Cheol-Min Park
Also filed as: PARK CHEOL MIN
29 granted patents·5 pending applications·1,263 citations·filing 2000–2017
98Inventor score
Top patents by PatentIndex Score
34 records- 0198US7973161B2Apoptosis promotersABBOTT LAB·Filed 2006·Granted Jul 5, 2011·70 cites·5 claims
- 0298US7767684B2Apoptosis promotersABBOTT LAB·Filed 2005·Granted Aug 3, 2010·107 cites·7 claims
- 0398US7642260B2Apoptosis promotersABBOTT LAB·Filed 2005·Granted Jan 5, 2010·82 cites·2 claims
- 0498US7390799B2Apoptosis promotersABBOTT LAB·Filed 2006·Granted Jun 24, 2008·331 cites·12 claims
- 0597US8686136B2Apoptosis promotersABBVIE INC·Filed 2012·Granted Apr 1, 2014·20 cites·2 claims
- 0697US8586754B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2010·Granted Nov 19, 2013·59 cites·8 claims
- 0797US8563735B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2009·Granted Oct 22, 2013·72 cites·4 claims
- 0897US8354404B2Apoptosis promotersABBOTT LAB·Filed 2011·Granted Jan 15, 2013·39 cites·8 claims
- 0997US8173811B2Apoptosis promotersBRUNCKO MILAN·Filed 2010·Granted May 8, 2012·50 cites·4 claims
- 1097US7709467B2Apoptosis promotersABBOTT LAB·Filed 2008·Granted May 4, 2010·50 cites·10 claims
- 1196US8614318B2Apoptosis promotersBRUNCKO MILAN·Filed 2006·Granted Dec 24, 2013·37 cites·2 claims
- 1296US8084607B2Apoptosis promotersBRUNCKO MILAN·Filed 2009·Granted Dec 27, 2011·43 cites·5 claims
- 1396US7585858B2N-sulfonylcarboximidamide apoptosis promotersABBOTT LAB·Filed 2005·Granted Sep 8, 2009·19 cites·4 claims
- 1496US7449485B2N-sulfonylurea apoptosis promotersABBOTT LAB·Filed 2008·Granted Nov 11, 2008·19 cites·2 claims
- 1596US7358251B2N-sulfonylurea apoptosis promotersABBOTT LAB·Filed 2005·Granted Apr 15, 2008·19 cites·3 claims
- 1695US8343967B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2012·Granted Jan 1, 2013·32 cites·2 claims
- 1794US8952157B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted Feb 10, 2015·22 cites·5 claims
- 1894US6624189B2Byrostatin analogues, synthetic methods and usesUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Sep 23, 2003·48 cites·30 claims
- 1993US7906505B2Apoptosis promotersABBOTT LAB·Filed 2010·Granted Mar 15, 2011·18 cites·4 claims
- 2092US7256286B2Bryostatin analogues, synthetic methods and usesUNIV LELAND STANFORD JUNIOR·Filed 2003·Granted Aug 14, 2007·29 cites·19 claims
- 2192US7030115B2N-sulfonylurea apoptosis promotersABBOTT LAB·Filed 2003·Granted Apr 18, 2006·32 cites·6 claims
- 2291US9303025B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2014·Granted Apr 5, 2016·11 cites·4 claims
- 2391US8338466B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesKUNZER AARON R·Filed 2010·Granted Dec 25, 2012·15 cites·6 claims
- 2490US9072748B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·10 claims
- 2589US9125913B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Sep 8, 2015·10 cites·6 claims
- 2687US7981888B21-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivativesABBOTT LAB·Filed 2008·Granted Jul 19, 2011·8 cites·7 claims
- 2784US8188077B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesDING HONG·Filed 2011·Granted May 29, 2012·8 cites·5 claims
- 2869US2010160322A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 2968US8853209B21-oxyalkyl-2-carboxy-7-nonsubstituted indole derivativesSONG XIAOHONG·Filed 2011·Granted Oct 7, 2014·2 cites·12 claims
- 3065US2010035879A1N-sulfonylcarboximidamide apoptosis promotersELMORE STEVEN W·Filed 2009·Application pending·0 cites
- 3164US9156856B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2012·Granted Oct 13, 2015·0 cites·6 claims
- 3261US2018251426A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2017·Application pending·0 cites
- 3354US2005159427A1N-acylsulfonamide apoptosis promotersFiled 2004·Application pending·0 cites
- 3454US2007270485A1Byrostatin analogues, synthetic methods and usesUNIV LELAND STANFORD JUNIOR·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cheol-Min Park files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →